Archangels Overview

Founded in 1992 and based in Edinburgh, Archangels is a leading business angel syndicate that has been at the forefront of early-stage investing in Scotland for over 30 years. The syndicate comprises more than 100 investor members and typically invests over £10 million per year in early-stage Scottish companies. Archangels focuses on disruptive technology with protectable intellectual property, which is difficult for competitors to replicate. Their core sectors include technology and life sciences. The syndicate has a strong track record, having invested over £160 million in innovative early-stage companies with the potential to scale globally. Archangels often co-invests alongside partners such as Scottish Enterprise and British Business Investments. Notable recent investments include a £6 million Series A funding round for CSignum, a provider of underwater wireless technology, and a £2.2 million investment in Bioliberty, a company developing a soft robotic glove. The syndicate has also achieved significant exits, including the sale of medical AI business Blackford Analysis to Bayer Pharma and optical platform business Optoscribe to Intel Corporation.

Is Archangels the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Archangels, along with a list of other relevant VCs, is available on Hopohopo.io.